ZXB-12354-31177 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Dose 1 — Moderna
2021-05-07
Dose 2 — Moderna
2022-01-05
Registered in v-safe
2022-01-06
Dose 3 — Moderna
2022-01-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-13
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-27
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-05
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-12
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2023-01-06
Survey response — 12 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-01-06
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-09
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-05	Moderna	No
2	2021-05-07	Moderna	No
3	2022-01-06	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2023-01-06	Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release